logo
Select company
Select metric
-2008.71%EBIT Margin
VS
Market
4
Sector
15
Industry
27
History
50
$ 3.98Close
$ 3.57 - $ 19.8 52-Week Range
Ticker Information

Ticker

CLSD

Company Name

CLEARSIDE BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CLEARSIDE BIOMEDICAL INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLSD - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -27M-2008.71%$ 1.34M
3/31/2025$ -30.1M-2098.74%$ 1.43M
12/31/2024$ -34.35M-2064.42%$ 1.66M
9/30/2024$ -31.88M-413.83%$ 7.7M
6/30/2024$ -33.46M-444.66%$ 7.52M
3/31/2024$ -34.97M-413.72%$ 8.45M
12/31/2023$ -32.48M-394.91%$ 8.23M
9/30/2023$ -37.32M-1687.74%$ 2.21M
6/30/2023$ -35.88M-2217.31%$ 1.62M
3/31/2023$ -34.58M-3514.53%$ 984K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CLEARSIDE BIOMEDICAL INC's latest trailing twelve months (TTM) EBIT % stands at -144.47%.
  • Over the past 5 years, CLEARSIDE BIOMEDICAL INC's average EBIT % has been -996.08%.
  • The median EBIT % for CLEARSIDE BIOMEDICAL INC during this period was -492.37%
  • CLEARSIDE BIOMEDICAL INC reached its highest EBIT % over the past 5 years at 1.27%.
  • The lowest EBIT % recorded by CLEARSIDE BIOMEDICAL INC in the same timeframe -3514.53%

CLEARSIDE BIOMEDICAL INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
IGC : IGC PHARMA INC -477.92%PLUR : PLURI INC -1609.96%RANI : RANI THERAPEUTICS HOLDINGS INC -2117.08%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1339.78%LSTA : LISATA THERAPEUTICS INC -1858.41%DTIL : PRECISION BIOSCIENCES INC -6097.94%RLYB : RALLYBIO CORP -5473.32%ICU : SEASTAR MEDICAL HOLDING CORP -1909.79%ONCO : ONCONETIX INC -3321.76%ADVM : ADVERUM BIOTECHNOLOGIES INC -18387.4%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for CLEARSIDE BIOMEDICAL INC is calculated as follows: EBIT [ $ -14.19M ] / Revenues [ $ 9.82M ]
(=) EBIT % [ -144.47% ]

CLSD - EBIT Margin, Last 5 years

-3514.53%

Minimum

Mar 31, 2023

1.27%

Maximum

Dec 31, 2021

-996.08%

Average

-492.37%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%